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Résumé en
anglais
Dual energy X-ray absorptiometry (DXA), histomorphometry and X-ray
microtomography (microCT) were used to assess effects of risedronate and
testosterone in a combined rat model of orchidectomy (ORX) and local paralysis
induced by botulinum neurotoxin (BTX). Four groups of mature rats were studied for
1 month: SHAM operated; ORX and right hindlimb immobilization (BTX); ORX +
BTX + risedronate or testosterone. Changes in bone and body composition were
measured by DXA (BMC, lean and fat mass), histomorphometry (BV/TV2D, Tb.Th
and microarchitectural parameters) and microCT (BV/TV3D, SMI and cortical
parameters). ORX and BTX had additive effects on bone loss since differences were
maximized on the immobilized bone. The decrease in BMC on the tibial metaphysis
reached −33.6% vs. −11.3% in the non-immobilized limb. BV/TV and Tb.N
decreased and Tb.Sp increased in both hindlimbs whereas Tb.Th was significantly
lower only in the immobilized limb. Decrease of tibial cortical area and thickness
was greater in the immobilized limb. Risedronate prevented BMC, BV/TV and
architecture loss but not reduction in Tb.Th. Cortical bone was preserved only in the
non-immobilized limb. Testosterone was unable to prevent trabecular and cortical
bone loss, but it prevents loss of whole body lean mass. In conclusion, ORX and BTX
resulted in additive effects on bone loss. Risedronate had protective effects on
trabecular bone loss but was less effective on cortical bone.
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